Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (191-200 of 368) with videos related to

Pageof 37
Sort By:
Canadian Liver Journal|August 22, 2022
The 8<sup>th</sup> Canadian Symposium on Hepatitis C virus: "Improving diagnosis and linkage to care"Sophie E Cousineau, Aysegul Erman, Lewis Liu, et al.
Seminars in Liver Disease|February 21, 2022
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-EliminationJeffrey V Lazarus, Camila A Picchio, Christopher J Byrne, et al.
Plos One|June 5, 2014
Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012Jason Grebely, Viviane Dias Lima, Brandon D L Marshall, et al.
Plos One|October 31, 2012
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugsRachel Sacks-Davis, Galina Daraganova, Campbell Aitken, et al.
Virology Journal|February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionBehzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
Ebiomedicine|September 7, 2016
The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)Naveed Z Janjua, Margot Kuo, Amanda Yu, et al.
Health Science Reports|April 10, 2020
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trialJason Grebely, Phillip Read, Evan B Cunningham, et al.
The Journal of Infectious Diseases|March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study designPeter Vickerman, Jason Grebely, Gregory J Dore, et al.
Journal of Viral Hepatitis|November 8, 2023
Incidence of hepatitis C virus infection in the prison setting: The SToP-C studyBehzad Hajarizadeh, Joanne M Carson, Marianne Byrne, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionJason Grebely, Son Truong Pham, Gail V Matthews, et al.
Pageof 37

Showing results (191-200 of 368) with videos related to

Sort By:
Pageof 37
Canadian Liver Journal|August 22, 2022
The 8<sup>th</sup> Canadian Symposium on Hepatitis C virus: "Improving diagnosis and linkage to care"Sophie E Cousineau, Aysegul Erman, Lewis Liu, et al.
Seminars in Liver Disease|February 21, 2022
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-EliminationJeffrey V Lazarus, Camila A Picchio, Christopher J Byrne, et al.
Plos One|June 5, 2014
Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012Jason Grebely, Viviane Dias Lima, Brandon D L Marshall, et al.
Plos One|October 31, 2012
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugsRachel Sacks-Davis, Galina Daraganova, Campbell Aitken, et al.
Virology Journal|February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionBehzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
Ebiomedicine|September 7, 2016
The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)Naveed Z Janjua, Margot Kuo, Amanda Yu, et al.
Health Science Reports|April 10, 2020
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trialJason Grebely, Phillip Read, Evan B Cunningham, et al.
The Journal of Infectious Diseases|March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study designPeter Vickerman, Jason Grebely, Gregory J Dore, et al.
Journal of Viral Hepatitis|November 8, 2023
Incidence of hepatitis C virus infection in the prison setting: The SToP-C studyBehzad Hajarizadeh, Joanne M Carson, Marianne Byrne, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionJason Grebely, Son Truong Pham, Gail V Matthews, et al.
Pageof 37